drugset / Trial / NCT02222233
Relative Bioavailability of BI 671800 HEA in Healthy Male Volunteers
Non-randomizedCrossoverOpen-labelTreatment
Summary
To determine the relative bioavailability of single doses of 200 mg BI 671800 HEA (choline) administered as a delayed release (enteric coated) tablet; or via the EnterionTM capsule as solution to the jejunum, ascending or descending colon, or as particulate to the ascending colon
Timeline
- Start
- 2010-01
- Primary completion
- 2010-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 671800 HEA | Unknown | 200 mg | Oral |
Indications
No indication recorded.